About Michael Watson

Global Vaccines & BioTech Leadership, R&D, Funding, Financing & Policy

• An experienced Executive Committee member of successful biotech and global commercial vaccines companies in UK, France and the USA for over 20 yrs. On company and foundation boards for over 10 yrs.
• Established and leading teams of 30 to 150 in R&D, clinical, medical, policy & advocacy, and fund-raising, that have taken 5 products to first in man, 3 to phase 2/3, and 3 to licensure, recommendation and launch.
• Experience with novel platforms & technologies, global blockbusters (Gardasil/HPV) and national and global vaccination innovation (Pediacel, Dengvaxia and Polio eradication).
• Generated over $200M in equity, governmental and foundation financing and funding, provided therapeutic area expertise for Moderna’s two largest financing rounds and IPO, and co-negotiated Acambis’s acquisition by Sanofi Pasteur.
• Leadership of Industry groups and foundation board membership have enabled an extensive network of global and national funders, policymakers, and influencers and high level expertise in the structure, drivers and barriers of global health and national policy and recommendations.